Inventor · disambiguated record
Jeegar P. Patel
Also filed as: PATEL JEEGAR P
1 granted patent·9 pending applications·0 citations·filing 2021–2024
14Inventor score
Files withKADMON CORP LLC10
Top patents by PatentIndex Score
10 records- 0170US11952369B2Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host diseaseKADMON CORP LLC·Filed 2023·Granted Apr 9, 2024·0 cites·2 claims
- 0269US2025136693A1Anti-PD-1 Antibodies and Fusion ProteinsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 0367US2024350493A1Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump InhibitorsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 0466US2023381179A1Methods of Treating Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantationKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 0563US2024024322A1Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump InhibitorsKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 0663US2024262810A1Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host DiseaseKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 0755US2023312724A1B7-H4 Antibodies and Anti-B7-H4 Antibody/IL-15 Fusion ProteinsKADMON CORP LLC·Filed 2022·Application pending·0 cites
- 0854US2024277713A1Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient SubpopulationsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 0952US2023416363A1Anti-PD-1 Antibodies and Fusion ProteinsKADMON CORP LLC·Filed 2021·Application pending·0 cites
- 1051US2024024323A1Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient SubpopulationsKADMON CORP LLC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeegar P. Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →